货号 | AGC-042-25ul |
描述 | Each antibody ordered from Alomone Labs is supplied with its corresponding control peptide (antigen), free of charge. A Rabbit Polyclonal Antibody to Kainate Receptor GluK5 |
反应种属 | H, M, R |
应用 | IH, WB |
供应商 | Alomone |
背景 | There are three super-families of Glutamate receptor defined by the specific agonist binding to them- NMDA, AMPA and Kainate. Several types of Kainate receptors have been cloned and classified. Two of these have a high affinity to Kainate (GLUK1 and GLUK2) while GLUK5, as well as other members of the family have a lower affinity1. GLUK5, GLUK6 and GLUK7 have a 75-80% identical amino acid sequence making them a separate subfamily from the other Kainate receptors. The GLUK5 receptor, similar to its subfamily members, is a ligand-gated ion channel. It has an extracellular N-terminus comprised of eight glycosylation consensus sites, four transmembrane domains arranged in a three-plus-one pattern with a large intracellular domain between units three and four and a C-terminus2. GLUK5 is expressed in DRG neuron cell bodies where currents in these cells are preferentially induced by Kainate and not AMPA3 and also in trigeminal neurons where kainate receptor antagonists are effective in a dural plasma protein extravasation model of migraine in rats4. Relatively little is known about the role of GLUK5 in pathologies. A study examining the role of the receptor in brain pathology, using GLUK5 antagonists on hippocampal cells slices, found that blocking of the Kainate receptor prevents the development of epileptic activity evoked by muscarinic antagonist. The administration of GLUK5 antagonists to conscious mice in the same study showed that the antagonist prevents limbic seizures induced by hippocampal pilocarpine perfusion without evident side effects. These findings suggest that GLUK5 antagonists may be effective in the treatment of epilepsy and further research in this field is required5. |
运输条件 | Ambient |
存放说明 | -20 |
纯度 | Affinity purified on immobilized antigen. |
参考文献 | 1.Weiss, B.et al.(2006)J. Pharmacol. Exp. Ther. 318,772. 2.Hollmann, M. and Heinemann, S.(1994),Annu. Rev. Neurosci. 17,31. 3.Partin, K.M.et al. (1993)Neuron11,1069. 4.Filla, S.A.et al.(2002)J. Med. Chem. 45,4383. 5.Smolders, I.et al.(2002)Nat. Neurosci. 5,794. |
本官网所有报价均为常温或者蓝冰运输价格,如有产品需要干冰运输,需另外加收干冰运输费。 |